Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-09-02 00:00:00 ET · period of report 2025-09-02 · accession 0001231615-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-09-02 | 2025-09-02 | AXSM | JEFFS ROGER | Dir | S - Sale | $123.68 | -13.5K | 57.5K | -19% | -$1.67M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-02 | S | D | 13,464 | $123.68 | 57,510 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $121.30 and $124.60. |